Cancer Clinical Trial
Official title:
Effectiveness of an Individual Mindfulness-based Intervention for Cancer Patients in a Advanced Stage of the Disease and Their Relatives
NCT number | NCT03492073 |
Other study ID # | 2 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 14, 2016 |
Est. completion date | December 20, 2018 |
Verified date | December 2017 |
Source | Instituto de Investigación Hospital Universitario La Paz |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The importance of emotional regulation interventions in cancer patients and primary
caregivers is clearly established, since it helps them manage their emotions.
The aim of the study was to analyze the differential effect between two Emotional Support
programs, one of them based on Mindfulness, and the other one Emotional Support as usual, on
advanced cancer patients (stage III & IV) admitted to a Madrid Community Hospital La Paz and
their relatives.
Status | Completed |
Enrollment | 30 |
Est. completion date | December 20, 2018 |
Est. primary completion date | December 15, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Older than 18 years old. - Being in treatment in one of the Oncology units at Hospital Universitario La Paz. - Capable of a minimum level of performance that allows intervention. - The doctor responsible of the patient considers that the program will help the cancer patient and that the patient is capable to participate on it. - Capable of understanding and giving his or her written informed consent. Exclusion Criteria: - Intellectual disability or cognitive impairment or dementia. - Insufficient knowledge of the language to understand and participate on the intervention program. - Serious mental illness in acute state at the moment of the beginning of the intervention. - Autolytic ideas at the moment of the assessment. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Instituto de Investigación Hospital Universitario La Paz |
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 Mar 3;85(5):365-76. — View Citation
Alfano CM, Rowland JH. Recovery issues in cancer survivorship: a new challenge for supportive care. Cancer J. 2006 Sep-Oct;12(5):432-43. Review. — View Citation
Cardaciotto L, Herbert JD, Forman EM, Moitra E, Farrow V. The assessment of present-moment awareness and acceptance: the Philadelphia Mindfulness Scale. Assessment. 2008 Jun;15(2):204-23. doi: 10.1177/1073191107311467. Epub 2008 Jan 9. — View Citation
Carlson LE. Mindfulness-based interventions for physical conditions: a narrative review evaluating levels of evidence. ISRN Psychiatry. 2012 Nov 14;2012:651583. doi: 10.5402/2012/651583. Print 2012. — View Citation
Fallowfield L, Jenkins V. Psychosocial/survivorship issues in breast cancer: are we doing better? J Natl Cancer Inst. 2014 Nov 27;107(1):335. doi: 10.1093/jnci/dju335. Print 2015 Jan. Review. — View Citation
Fors EA, Bertheussen GF, Thune I, Juvet LK, Elvsaas IK, Oldervoll L, Anker G, Falkmer U, Lundgren S, Leivseth G. Psychosocial interventions as part of breast cancer rehabilitation programs? Results from a systematic review. Psychooncology. 2011 Sep;20(9):909-18. doi: 10.1002/pon.1844. Epub 2010 Sep 6. Review. — View Citation
Gil F, Grassi L, Travado L, Tomamichel M, Gonzalez JR; Southern European Psycho-Oncology Study Group. Use of distress and depression thermometers to measure psychosocial morbidity among southern European cancer patients. Support Care Cancer. 2005 Aug;13(8):600-6. Epub 2005 Mar 11. — View Citation
Gort AM, March J, Gómez X, de Miguel M, Mazarico S, Ballesté J. [Short Zarit scale in palliative care]. Med Clin (Barc). 2005 May 7;124(17):651-3. Spanish. — View Citation
Hewitt M, Breen N, Devesa S. Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey. J Natl Cancer Inst. 1999 Sep 1;91(17):1480-6. — View Citation
Lotfi-Jam K, Carey M, Jefford M, Schofield P, Charleson C, Aranda S. Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. J Clin Oncol. 2008 Dec 1;26(34):5618-29. doi: 10.1200/JCO.2007.15.9053. Epub 2008 Nov 3. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mindfulness | Philadelphia Mindfulness Scale (PHLMS). Attention to the present moment and Acceptance. | At day one of the intervention | |
Primary | Mindfulness | Philadelphia Mindfulness Scale (PHLMS). Attention to the present moment and Acceptance. | At the end of the six sessions(each session is every three days) | |
Secondary | Quality of life. | Quality of life in advanced-cancer patients. (EORTC QLQ - C15-PAL). | At day one of the intervention | |
Secondary | Caregiver emotional burden. | Zarit. Emotional burden of the main caregiver. Impact of caring, interpersonal relationship and self-efficacy expectations. | At day one of the intervention | |
Secondary | Emotional distress | Distress thermometer (DT), scores from 1 to 10. Emotional distress. | At day one of the intervention | |
Secondary | Daily life Performance | Karnofsky Performance Status. It gives a measure of the dependency level of the patients, and the level of support that the cancer patient needs. | At day one of the intervention | |
Secondary | Number of sessions | number of sessions of emotional support intervention or mindfulness emotional support intervention | At the end of the six sessions(each session is every three days) | |
Secondary | Quality of life. | Quality of life in advanced-cancer patients. (EORTC QLQ - C15-PAL). | At the end of the six sessions(each session is every three days) | |
Secondary | Caregiver emotional burden. | Zarit. Emotional burden of the main caregiver. Impact of caring, interpersonal relationship and self-efficacy expectations. | At the end of the six sessions(each session is every three days) | |
Secondary | Emotional distress | Distress thermometer (DT), scores from 1 to 10. Emotional distress. | At the end of the six sessions(each session is every three days) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|
||
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|